Venous Thrombosis from Air Travel: The LONFLIT3 Study

Abstract

The LONFLIT1 and 2 studies established that in high-risk subjects after long (> 10 hours) flights, the incidence of deep venous thrombosis (DVT) may be between 4% and 6%. The LONFLIT3 study aimed to evaluate methods of prevention in high-risk subjects. Of 467 subjects contacted for the study, 300 were included. These 300 subjects at high risk for DVT were randomized, after informed consent, into three groups: 1) a control group that had no prophylaxis; 2) an aspirin treatment group, in which patients were treated with 400 mg , (tablets of oral, soluble aspirin; one dose daily for 3 days, starting 12 hours before the beginning of the flight); and 3) a low-molecular-weight heparin (LMWH) group, in which one dose of enoxaparine was injected between 2 and 4 hours before the flight. The dose was weight-adjusted (1000 IU [equivalent to 0.1 mL] per 10 kg of body weight). Subjects with potential problems due to prophylaxis with aspirin or LMWH or at risk of drug interactions were excluded. Of the 100 included subjects in each group, a total of 249 subjects completed the study (dropouts due to low compliance or traveling/connections problems were 17%). Age and sex distribution were comparable in the three groups as well as risk distributions. Mean age was 47 (range, 28-75; SD, 11; 65% males). Of the 82 subjects in the control group, there were 4.82% of subjects with DVT with two superficial thromboses. In total 4.8% of limbs suffered a thrombotic event. Of 84 subjects in the aspirin treatment group, there were 3.6% of patients with DVT and three superficial thrombosis. In total 3.6% of limbs had a throm botic event. In the LMWH group (82 subjects), there were no cases of DVT. One superficial thrombosis was documented. In total only 0.6% of limbs had a thrombotic event (p < 0.002 in comparison with the other two groups). DVT was asymptomatic in 60% of subjects; 85% of DVTs were observed in passengers in non-aisle seats. Mild gastrointestinal symptoms were reported in 13% of patients taking aspirin. One dose of LMWH is an important option to consider in high-risk subjects during long-haul flights.

Get full access to this article

View all access options for this article.

References

Geroulakos G. , Hossain J. , Tran T. : Economy-class syndrome presenting as phlegmasia caerulea dolens. Eur J Vasc Endovasc Surg 20:102-104, 2000.

Perry K. : Blood clot kills woman after flight. The Guardian, Oct. 23, 2001.

Homans J. : Thrombosis of the deep leg veins due to prolonged sitting. N Engl J Med 250:148-149, 1954.

Symington IS , Stack Bhr : Pulmonary thromboembolism after travel. Br J Chest 17:138-140, 1977.

Simpson K. : Shelter deaths from pulmonary embolism. Lancet 11:744, 1940.

Ferrari E. , Chevallier T. , Chapelier A. , et al: Travel as a risk factor for venous thromboembolic disease: A case control study. Chest 115:440-444, 1999.

Cruickshank JM , Gorlin R. , Jennett B. : Air travel and thrombotic episodes: The economy class syndrome. Lancet 2:497-498, 1988.

Kraaijenhagen R. , Haverkamp D. , Koopman Mmw , et al: Travel and risk of venous thrombosis . Lancet 356:1492-1493, 2000 .

Sarvesvaran R. : Sudden natural deaths associated with commercial air travel. Med Sci Law 26:35-38, 1986.

10.

Landgraf H. , Vanselow B. , Schulte-Huerman D. , et al: Economy class syndrome: Rheology fluid balance and lower leg oedema during a simulated 12-hour long-distance flight. Aviat Space Environ Med 65:930-935, 1994.

11.

AMA Commission on Emergency Services : Medical aspects of transportation aboard commercial aircraft. JAMA 247:1007-1011, 1982.

12.

Gertler JP , Perry L. , L'Italien G. , et al: Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg 18:939-946, 1993.

13.

Bendz B. , Rostrup M. , Sevre K. , et al: Association between acute hypobaric hypoxia and activation of coagulation in human beings. Lancet 356:1657-1658, 2000.

14.

Belcaro G. , Geroulakos G. , Nicolaides AN , et al: Venous thromboembolism from air travel. The Lonflit study. Angiology 52:369-374, 2001.

15.

Scurr JH , Machin SJ , Bayley S. , et al: Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: A randomised trial. Lancet 357: 1485-1489, 2001.

16.

Webster B. : Airlines tell passengers to stretch legs. Times Jan. 12, 2001:1.

17.

Geroulakos G. : The risk of venous thromboembolism from air travel: The evidence is only circumstantial [editorial]. BMJ 322:188, 2001.

18.

Belcaro G. , Stansby G. , Nicolaides AN : The Venous Clinic. London: Imperial College Press, 1999.

19.

Belcaro G. , Nicolaides AN : Noninvasive investigations in vascular disease. London : Imperial College Press, 2000.

20.

Calder S. : Exercise your constitutional rights in the air. The Independent, Jan. 13, 2001.

21.

The fit flyer. High Life Magazine, Dec. 2000.

22.

Data from USA

Today Research ( 2000).

23.

James J. : Perils of passage. Time 2001:54-59.

24.

Cesarone MR , Meli E. : Volare con sicurezza. Jet-leg. Il problema dell'edema e della trombosi in voli di lunga durata. Ediz Minerva Medica, Turin 2001.